Background: The incidence of asthma and allergic
rhinitis (AR) is significantly increased, especially in
younger children. Current treatment for children with
asthma and allergic rhinitis include allergen avoidance,
standard pharmacotherapy, and immunotherapy. Since
standard pharmacotherapy is prescribed for symptoms,
immunotherapy at present plays an important role in the
treatment of allergic diseases. This article presents insights
into the up-to-date understanding of immunotherapy in
the treatment of children with allergic rhinitis and asthma.